Logo
RIVAROXABAN MARKET ANALYSIS
  2. / Market Insights
  3. Rivaroxaban Market Analysis
all report title image

RIVAROXABAN MARKET ANALYSIS

Rivaroxaban Market, By Indication (Atrial Fibrillation, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Prophylaxis of Venous Thromboembolism (VTE), and Others), By Formulation (Tablets and Suspension), By Patient Type (Adults and Paediatrics), By Distribution Channel (Hospitals and Clinics, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI1962
  • Pages :150
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Rivaroxaban Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Bayer AG
  • Janssen Pharmaceuticals, Inc.
  • Interquim SA
  • Natco Pharma
  • Mylan N.V.
  • Sandoz (a Novartis division)
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Zydus Cadila
  • Apotex Inc.
  • Hetero Labs Limited
  • Fresenius Kabi AG
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals
  • Reddy's Laboratories
  • Bristol-Myers Squibb
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Eisai Co., Ltd.
  • Amgen Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Global Rivaroxaban Market to Surpass US$ 26.11 Mn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.